List of Excipients in API sonrotoclax
Excipients in NDA-approved (novel) drugs containing sonrotoclax
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| BeOne Medicines USA Inc | BEQALZI | sonrotoclax | 72579-020 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | 2031-05-13 |
| BeOne Medicines USA Inc | BEQALZI | sonrotoclax | 72579-020 | CELLULOSE, MICROCRYSTALLINE | 2031-05-13 |
| BeOne Medicines USA Inc | BEQALZI | sonrotoclax | 72579-020 | CROSCARMELLOSE SODIUM | 2031-05-13 |
| BeOne Medicines USA Inc | BEQALZI | sonrotoclax | 72579-020 | FD&C BLUE NO. 1 ALUMINUM LAKE | 2031-05-13 |
| BeOne Medicines USA Inc | BEQALZI | sonrotoclax | 72579-020 | FD&C RED NO. 40 ALUMINUM LAKE | 2031-05-13 |
| BeOne Medicines USA Inc | BEQALZI | sonrotoclax | 72579-020 | HYPROMELLOSE ACETATE SUCCINATE | 2031-05-13 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for sonrotoclax
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
sonrotoclax drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| BeOne Medicines USA Inc | sonrotoclax | 72579-020 |
| >Company | >Ingredient | >NDC |
sonrotoclax drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
sonrotoclax drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| BeOne Medicines USA Inc | sonrotoclax | 72579-020 |
| >Company | >Ingredient | >NDC |
sonrotoclax drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
sonrotoclax drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| BeOne Medicines USA Inc | sonrotoclax | 72579-020 |
| >Company | >Ingredient | >NDC |
sonrotoclax drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
sonrotoclax drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| BeOne Medicines USA Inc | sonrotoclax | 72579-020 |
| >Company | >Ingredient | >NDC |
sonrotoclax drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40 ALUMINUM LAKE
sonrotoclax drug variants containing FD&C RED NO. 40 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| BeOne Medicines USA Inc | sonrotoclax | 72579-020 |
| >Company | >Ingredient | >NDC |
sonrotoclax drug variants not containing FD&C RED NO. 40 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE ACETATE SUCCINATE
sonrotoclax drug variants containing HYPROMELLOSE ACETATE SUCCINATE
| Company | Ingredient | NDC |
|---|---|---|
| BeOne Medicines USA Inc | sonrotoclax | 72579-020 |
| >Company | >Ingredient | >NDC |
sonrotoclax drug variants not containing HYPROMELLOSE ACETATE SUCCINATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
sonrotoclax drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| BeOne Medicines USA Inc | sonrotoclax | 72579-020 |
| >Company | >Ingredient | >NDC |
sonrotoclax drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
sonrotoclax drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| BeOne Medicines USA Inc | sonrotoclax | 72579-020 |
| >Company | >Ingredient | >NDC |
sonrotoclax drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
sonrotoclax drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| BeOne Medicines USA Inc | sonrotoclax | 72579-020 |
| >Company | >Ingredient | >NDC |
sonrotoclax drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SOYBEAN LECITHIN
sonrotoclax drug variants containing SOYBEAN LECITHIN
| Company | Ingredient | NDC |
|---|---|---|
| BeOne Medicines USA Inc | sonrotoclax | 72579-020 |
| >Company | >Ingredient | >NDC |
sonrotoclax drug variants not containing SOYBEAN LECITHIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
sonrotoclax drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| BeOne Medicines USA Inc | sonrotoclax | 72579-020 |
| >Company | >Ingredient | >NDC |
sonrotoclax drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
sonrotoclax drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| BeOne Medicines USA Inc | sonrotoclax | 72579-020 |
| >Company | >Ingredient | >NDC |
sonrotoclax drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch